KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Current Assets: 2015-2024

Historic Current Assets for BeOne Medicines (ONC) over the last 10 years, with Dec 2024 value amounting to $4.0 billion.

  • BeOne Medicines' Current Assets rose 44.81% to $5.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year increase of 44.81%. This contributed to the annual value of $4.0 billion for FY2024, which is 5.04% down from last year.
  • Latest data reveals that BeOne Medicines reported Current Assets of $4.0 billion as of FY2024, which was down 5.04% from $4.2 billion recorded in FY2023.
  • BeOne Medicines' Current Assets' 5-year high stood at $7.6 billion during FY2021, with a 5-year trough of $3.1 billion in FY2022.
  • In the last 3 years, BeOne Medicines' Current Assets had a median value of $4.0 billion in 2024 and averaged $3.8 billion.
  • Per our database at Business Quant, BeOne Medicines' Current Assets skyrocketed by 323.02% in 2020 and then tumbled by 59.33% in 2022.
  • Over the past 5 years, BeOne Medicines' Current Assets (Yearly) stood at $5.0 billion in 2020, then skyrocketed by 53.48% to $7.6 billion in 2021, then plummeted by 59.33% to $3.1 billion in 2022, then surged by 35.74% to $4.2 billion in 2023, then declined by 5.04% to $4.0 billion in 2024.